JPMorgan believes that accelerating cloud adoption and artificial intelligence integration could boost shares of Autodesk . The bank upgraded the design software maker to overweight from neutral.

Flora, the creator of an “intelligent canvas” platform for creative professionals, has raised $42 million in an early-stage round with a goal to tackle the fragmentation around generative artificial ...

Why one must take care when coding with generative AI. The challenges of vibe coding. How to get tips on Javascript coding. What I did find is that working with chatbots is much like programming, but ...

Nov 25 (Reuters) - Design software maker Autodesk (ADSK.O), opens new tab forecast fourth-quarter revenue and profit above Wall Street estimates on Tuesday, supported by steady subscription renewals ...

SCI-Arc alumni continue to make an indelible mark on the global design landscape, pioneering new approaches in architecture, technology, and interdisciplinary practices. With a reputation for ...

An MIT team used artificial intelligence to design novel antibiotics, two of which showed promise against MRSA and gonorrhea. With help from artificial intelligence, MIT researchers have designed ...

Creative design giant Adobe is beefing up the products it offers businesses to include custom generative AI models. Adobe launched Adobe AI Foundry on Monday, a new offering that allows enterprises to ...

Learn how to use generative fill on moving videos in After Effects! This tutorial teaches step-by-step techniques to seamlessly enhance dynamic footage with AI-powered effects. #AfterEffects ...

Autodesk, Inc. (NASDAQ:ADSK) is one of the AI Stocks on the Market’s Radar. On October 8, Piper Sandler analyst Clarke Jeffries reiterated an Overweight rating on the stock with a $373.00 price target ...

Autodesk's Forma Building Design aims to give architects and engineers level 200 and 300 design capabilities such as this daylight analysis while not replacing the detailed geometry in Revit but, ...

Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...